A Multi-Billion-Dollar Drug Market

In the latest Baron Insights, our investment team does a deep dive into a new class of weight loss drugs and why they have the potential to be the largest drug class in the history of health care.

Baron Capital Insight Series | April 2024

Our veteran team of small-cap portfolio managers break down the current market conditions in the space and which new ideas they think have the potential to capitalize on them.

Latest Insights & Commentary